MA32406B1 - Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens - Google Patents

Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens

Info

Publication number
MA32406B1
MA32406B1 MA33446A MA33446A MA32406B1 MA 32406 B1 MA32406 B1 MA 32406B1 MA 33446 A MA33446 A MA 33446A MA 33446 A MA33446 A MA 33446A MA 32406 B1 MA32406 B1 MA 32406B1
Authority
MA
Morocco
Prior art keywords
azotes
antibacterials
compounds containing
containing tricyclic
formula
Prior art date
Application number
MA33446A
Other languages
Arabic (ar)
English (en)
Inventor
Carlos Alemparte-Gallardo
Christopher Barfoot
David Barros-Aguirre
Monica Cacho-Izquierdo
Roman Jose Maria Fiandor
Alan Joseph Hennessy
Neil David Pearson
Modesto Jesus Remuinan-Blanco
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA32406B1 publication Critical patent/MA32406B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne des composés représentés par la formule (i) ou des sels ou des oxydes de n pharmaceutiquement acceptables, la formule (i) (formule chimique représentée), des compositions pharmaceutiques comprenant ces composés, leur utilisation thérapeutique, en particulier contre la tuberculose, et des procédés de préparation de celle-ci.
MA33446A 2008-05-23 2010-12-20 Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens MA32406B1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08382018 2008-05-23
EP08382057 2008-10-17
EP08382044 2008-10-17
PCT/EP2009/056177 WO2009141398A1 (fr) 2008-05-23 2009-05-20 Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens

Publications (1)

Publication Number Publication Date
MA32406B1 true MA32406B1 (fr) 2011-06-01

Family

ID=40874958

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33446A MA32406B1 (fr) 2008-05-23 2010-12-20 Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens

Country Status (24)

Country Link
US (1) US8097628B2 (fr)
EP (1) EP2300476B1 (fr)
JP (1) JP5474941B2 (fr)
KR (1) KR20110016947A (fr)
CN (1) CN102105473B (fr)
AR (1) AR071869A1 (fr)
AU (1) AU2009248786B2 (fr)
BR (1) BRPI0912995A2 (fr)
CA (1) CA2725726A1 (fr)
CL (1) CL2009001267A1 (fr)
CO (1) CO6321284A2 (fr)
CR (1) CR11838A (fr)
DO (1) DOP2010000342A (fr)
EA (1) EA018817B1 (fr)
ES (1) ES2455496T3 (fr)
IL (1) IL209270A (fr)
MA (1) MA32406B1 (fr)
MX (1) MX2010012732A (fr)
NZ (1) NZ589062A (fr)
PE (1) PE20091927A1 (fr)
TW (1) TW201008941A (fr)
UY (1) UY31839A (fr)
WO (1) WO2009141398A1 (fr)
ZA (1) ZA201007945B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY155535A (en) 2008-05-23 2015-10-30 Novartis Ag Derivatives of quinolines and quinoxalines as protien tyrosine kinase inhibitors
EP2352734A1 (fr) 2008-10-17 2011-08-10 Glaxo Group Limited Composés azotés tricycliques utilisés comme agents antibactériens
WO2011140183A1 (fr) * 2010-05-04 2011-11-10 Alkermes, Inc. Procédé de synthèse de lactames oxydés
WO2013164769A1 (fr) 2012-05-02 2013-11-07 Lupin Limited Composés substitués de pyridine en tant que modulateurs de crac
CN103113291B (zh) * 2013-02-04 2015-03-04 浙江大学 一种3位烯基吡啶衍生物的合成方法
EP3639824A1 (fr) * 2014-08-22 2020-04-22 GlaxoSmithKline Intellectual Property Development Limited Composés tricyclique contenant de l'azote pour le traitement de l'infection à neisseria gonorrhoeae
JP2019517546A (ja) 2016-06-08 2019-06-24 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニＡｚｉｅｎｄｅ Ｃｈｉｍｉｃｈｅ Ｒｉｕｎｉｔｅ Ａｎｇｅｌｉｎｉ Ｆｒａｎｃｅｓｃｏ Ａ．Ｃ．Ｒ．Ａ．Ｆ．Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 新しい抗菌性化合物
WO2021198981A1 (fr) 2020-04-01 2021-10-07 Janssen Biopharma, Inc. Composés antiviraux et leurs utilisations
JPWO2023210599A1 (fr) 2022-04-25 2023-11-02

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2344523T3 (es) * 2005-12-22 2010-08-30 Glaxo Group Limited Compuestos heterociclicos, su preparacion y su uso como agentes antibacterianos.
ATE481406T1 (de) * 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0707706D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
JP5389013B2 (ja) * 2007-04-20 2014-01-15 グラクソ グループ リミテッド 抗菌剤としての三環式含窒素化合物

Also Published As

Publication number Publication date
EA018817B1 (ru) 2013-10-30
AR071869A1 (es) 2010-07-21
UY31839A (es) 2009-12-14
CO6321284A2 (es) 2011-09-20
JP5474941B2 (ja) 2014-04-16
AU2009248786B2 (en) 2013-04-04
NZ589062A (en) 2012-06-29
AU2009248786A1 (en) 2009-11-26
ES2455496T3 (es) 2014-04-15
PE20091927A1 (es) 2010-01-21
BRPI0912995A2 (pt) 2015-10-13
CN102105473B (zh) 2013-05-08
JP2011520943A (ja) 2011-07-21
EA201071352A1 (ru) 2011-06-30
EP2300476A1 (fr) 2011-03-30
MX2010012732A (es) 2010-12-07
US8097628B2 (en) 2012-01-17
DOP2010000342A (es) 2010-11-30
CL2009001267A1 (es) 2010-12-31
TW201008941A (en) 2010-03-01
ZA201007945B (en) 2011-08-31
WO2009141398A1 (fr) 2009-11-26
IL209270A0 (en) 2011-01-31
KR20110016947A (ko) 2011-02-18
CA2725726A1 (fr) 2009-11-26
IL209270A (en) 2013-09-30
US20090306089A1 (en) 2009-12-10
CR11838A (es) 2011-03-25
CN102105473A (zh) 2011-06-22
EP2300476B1 (fr) 2014-01-08

Similar Documents

Publication Publication Date Title
MA32406B1 (fr) Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens
UA109010C2 (en) Morpholino pyrividines and their use in therapy
MY198204A (en) Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
MX348823B (es) Formulaciones estables de linaclotida.
MY183312A (en) Pharmaceutical formulation
WO2011006935A3 (fr) Dérivés de tétrazole
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
MX2012001660A (es) Formulaciones que contienen linaclotida para adminstracion oral.
MY187718A (en) Pharmaceutical formulations
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
IN2012DN01292A (fr)
MX2009013501A (es) Compuestos piperidinicos y sus usos.
WO2012135615A3 (fr) Enopeptines, utilisations de celles-ci, et procédés de synthèse de celles-ci
EA201590364A1 (ru) Применение орвепитанта, его солей и кристаллических форм и композиций, его содержащих, для лечения зуда
EA201290229A1 (ru) Производные спиролактама и их применение
MX2009010374A (es) Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos.
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
WO2010121675A3 (fr) Thiazolyl-benzimidazoles
MX2011013869A (es) Agentes antihelminticos y su uso.
UY32247A (es) Nuevos compuestos de aminociclohexilo, composiciones farmacéuticas de los mismos y aplicaciones
MY169266A (en) Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide